Company intelligence / Profile preview

Superstatins Pharmaceuticals

Rockville, Maryland, United States

Ownership: Private
Employees: ~637
Development stage: Other

Overview

Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The company leverages its proprietary drug delivery technologies, such as MicroFusion and SoluMatrix, to create novel formulations of known drugs that improve efficacy, safety, and patient compliance. Its commercial portfolio is anchored by Trokendi XR and Oxtellar XR for epilepsy, as well as Qelbree for the treatment of ADHD in both pediatric and adult populations. Supernus continues to advance a diverse pipeline targeting significant unmet needs in Parkinson's disease, migraine, and treatment-resistant depression.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

ShireUnited TherapeuticsNavitor Pharmaceuticals

Beyond the preview

Go deeper on Superstatins Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Superstatins Pharmaceuticals.

Explore the full profile